Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Autoimmune Disorders

  Free Subscription


16.06.2025

1 Ann Neurol
1 Brain
10 Diabet Med
8 Diabetes Res Clin Pract
2 Intern Med
1 J Nephrol
4 J Neuroimmunol
6 J Neurol
3 Kidney Int
1 Mult Scler
1 N Engl J Med
2 Neurol Clin Pract
2 Neurology
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. DISANTO G, Sacco R, Mallucci G, Zecca C, et al
    Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation Dynamics in Multiple Sclerosis.
    Ann Neurol. 2025 Jun 11. doi: 10.1002/ana.27281.
    PubMed         Abstract available


    Brain

  2. CUNNIFFE NG
    Extending the role of neurofilament light in multiple sclerosis beyond measuring irreversible neurodegeneration.
    Brain. 2025 Jun 9:awaf224. doi: 10.1093.
    PubMed        


    Diabet Med

  3. STENOV V, Due-Christensen M, Christensen JN, Willaing I, et al
    Discovering the hidden emotional burden: Systematic screening for diabetes distress in adults with type 1 diabetes in nurse-led routine diabetes care.
    Diabet Med. 2025 May 15:e70064. doi: 10.1111/dme.70064.
    PubMed         Abstract available

  4. NAGEL KE, Dearth-Wesley T, Herman AN, Whitaker RC, et al
    The association of environmental mastery and diabetes distress among young adults with type 1 diabetes.
    Diabet Med. 2025 May 9:e70061. doi: 10.1111/dme.70061.
    PubMed         Abstract available

  5. HESSLER DM, Polonsky WH, Strycker L, Naranjo D, et al
    Stability and impact of diabetes distress over time: The potential value and uses of the type 1 diabetes distress assessment system (T1-DDAS).
    Diabet Med. 2025 May 8:e70066. doi: 10.1111/dme.70066.
    PubMed         Abstract available

  6. LIM RJ, Crosby NE, Harray AJ, Begley A, et al
    Teaching Kitchens: An innovative program for enhancing self-management skills in adolescents living with type 1 diabetes (T1D) - A feasibility study.
    Diabet Med. 2025 May 3:e70053. doi: 10.1111/dme.70053.
    PubMed         Abstract available

  7. BADDOCK S, Raven L, Abeygunasekara G, Roche M, et al
    Management of diabetic ketoacidosis in adult inpatients: A retrospective analysis of rates of hypoglycaemia with variable-rate and fixed-rate intravenous insulin infusion protocols.
    Diabet Med. 2025 May 1:e70063. doi: 10.1111/dme.70063.
    PubMed         Abstract available

  8. DLUGATCH R, Rankin D, Evans M, Oliver N, et al
    Improving access to diabetes technologies in children and young people with type 1 diabetes: Healthcare professionals' perspectives and views.
    Diabet Med. 2025 Apr 25:e70058. doi: 10.1111/dme.70058.
    PubMed         Abstract available

  9. MICHAELS VR, Boucsein A, Zhou Y, Jones SD, et al
    Impact of Simplera Sync sensors and Extended Wear Infusion Sets on glycaemia and system performance of the MiniMed 780G system in children and young adults with previously high HbA1c.
    Diabet Med. 2025;42:e70048.
    PubMed         Abstract available

  10. ASWATH KRISHNA S, Venkatesan U, Amutha A, Jebarani S, et al
    Cardiovascular disease risk prediction and profiling among Asian Indians with young-onset type 1 and type 2 diabetes.
    Diabet Med. 2025 Feb 28:e70020. doi: 10.1111/dme.70020.
    PubMed         Abstract available

  11. NOVODVORSKY P, Bernjak A, Downs E, Smith A, et al
    Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia.
    Diabet Med. 2025 Feb 27:e70019. doi: 10.1111/dme.70019.
    PubMed         Abstract available

  12. MARKHAM-LEE Z, Bhagat-Jones S, Carlton J, Frankel A, et al
    Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshop.
    Diabet Med. 2025 Feb 27:e70013. doi: 10.1111/dme.70013.
    PubMed         Abstract available


    Diabetes Res Clin Pract

  13. OGLE GD, Wang F, Haynes A, Gregory GA, et al
    Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0.
    Diabetes Res Clin Pract. 2025;225:112277.
    PubMed         Abstract available

  14. HAUGSTVEDT A, Nilsen RM, Breivik K, Iversen MM, et al
    Comparison of information provided on diabetes distress when using PAID-20, PAID-11 or PAID-5. A registry-based study applying IRT analyses among 10,190 adults with type 1 diabetes in Norway.
    Diabetes Res Clin Pract. 2025;225:112267.
    PubMed         Abstract available

  15. MACHALKOVA L, Reiterova E, Bartonickova D, Durdakova M, et al
    Satisfaction of adult patients using continuous subcutaneous insulin infusion or multiple daily injections with type 1 diabetes mellitus.
    Diabetes Res Clin Pract. 2025;225:112265.
    PubMed         Abstract available

  16. WANG W, Qiao J, Man F, Luo J, et al
    Evaluation of cardiovascular risk according to the 2019 ESC/EASD guidelines in type 1 diabetes mellitus patients: A population-based survey study.
    Diabetes Res Clin Pract. 2025;225:112245.
    PubMed         Abstract available

  17. BOWEN L, Carey IM, Chaudhry UAR, DeWilde S, et al
    HbA1c variability and all-cause mortality in type 1 and type 2 diabetes: A population-based cohort study using electronic health records.
    Diabetes Res Clin Pract. 2025;225:112229.
    PubMed         Abstract available

  18. NGAN J, O'Neal DN, Lee MH, Kong YW, et al
    Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes Part A: Benefits of sodium-glucose co-transporter inhibitor use in type 1 diabetes.
    Diabetes Res Clin Pract. 2025;225:112278.
    PubMed         Abstract available

  19. WERSALL JH, Adolfsson P, Ekelund J, Forsander G, et al
    Is diabetic ketoacidosis at diagnosis of type 1 diabetes associated with secondary episodes of ketoacidosis? A nationwide longitudinal study of Swedish children from 2012 to 2019.
    Diabetes Res Clin Pract. 2025;225:112282.
    PubMed         Abstract available

  20. SLOMINSKI B, Gladysz J, Skrzypkowska M, Ryba-Stanislawowska M, et al
    Black Death protective gene mutation shows ambiguous role in type 1 diabetes, its complications, and common viral infections.
    Diabetes Res Clin Pract. 2025;225:112287.
    PubMed         Abstract available


    Intern Med

  21. ADACHI K, Okimoto E, Ebisutani Y, Matsubara Y, et al
    Mucosal Atrophy of the Fornix as an Important Endoscopic Finding for an Autoimmune Gastritis Diagnosis.
    Intern Med. 2025 Jun 12. doi: 10.2169/internalmedicine.5638.
    PubMed         Abstract available

  22. AKAMINE H, Uzawa A, Kuwabara S, Suzuki S, et al
    Association between Myasthenia Gravis and Smoking.
    Intern Med. 2025 Jun 12. doi: 10.2169/internalmedicine.5310.
    PubMed         Abstract available


    J Nephrol

  23. GOGGINS E, DeLaat A, Barr B, Taliercio J, et al
    Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts.
    J Nephrol. 2025 Jun 11. doi: 10.1007/s40620-025-02313.
    PubMed         Abstract available


    J Neuroimmunol

  24. MIYAKE S, Katsura Y, Baba M, Tomizawa-Shinohara H, et al
    Anti-IL-6R antibody treatment changes microglial phenotype in AQP4 peptide-immunized mice, leading to suppression of myelitis severity.
    J Neuroimmunol. 2025;405:578644.
    PubMed         Abstract available

  25. SAGHARICHI M, Aalipour MA, Eghbal E, Javandoust Gharehbagh F, et al
    Autoimmune encephalitis and delayed diagnosis in common variable immunodeficiency: A case report and review of literature.
    J Neuroimmunol. 2025;406:578662.
    PubMed         Abstract available

  26. JOHNSON CB, Fehmi J, Rinaldi S
    The immunology and neuropathology of the autoimmune nodopathies.
    J Neuroimmunol. 2025;406:578665.
    PubMed         Abstract available

  27. HOSHINA Y, Smith TL, Mstat AD, Wong KH, et al
    An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote.
    J Neuroimmunol. 2025;405:578651.
    PubMed         Abstract available


    J Neurol

  28. HERAUD C, Bresch S, Bourg V, Landes-Chateau C, et al
    Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment.
    J Neurol. 2025;272:451.
    PubMed         Abstract available

  29. SAMADZADEH S, Chan F, Francis A, Sani L, et al
    The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD.
    J Neurol. 2025;272:453.
    PubMed         Abstract available

  30. ZANETTA C, Gasperini C, Amato MP, Centonze D, et al
    Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective.
    J Neurol. 2025;272:446.
    PubMed         Abstract available

  31. VORASOOT N, Isitan-Alkawadri C, Pillai B, Miske R, et al
    DAGLA autoantibody experience at Mayo Clinic.
    J Neurol. 2025;272:460.
    PubMed        

  32. BURGUET VILLENA F, Cerda-Fuertes N, Hofer L, Schadelin S, et al
    Retinal neuronal loss and progression independent of relapse activity in multiple sclerosis.
    J Neurol. 2025;272:454.
    PubMed         Abstract available

  33. HEWAMADDUMA C, Freimer M, Genge A, Leite MI, et al
    Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis.
    J Neurol. 2025;272:457.
    PubMed         Abstract available


    Kidney Int

  34. ZAND L, Russo I, Vargas-Brochero MJ, Nasr SH, et al
    Phospholipase A2receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2receptor on kidney biopsy.
    Kidney Int. 2025 Jun 6:S0085-2538(25)00428-4. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available

  35. KOOIENGA L, Lee EY, Kim SG, Thomas H, et al
    Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy.
    Kidney Int. 2025 May 30:S0085-2538(25)00414-4. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available

  36. LIU P, Liu S, Dalal V, Lane J, et al
    Evaluation of Methodologies in Anti-nephrin Autoantibody Detection.
    Kidney Int. 2025 Jun 7:S0085-2538(25)00430-2. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available


    Mult Scler

  37. STEIN C, O'Keeffe F, Brosnan M, Flynn C, et al
    Cognitive reserve in multiple sclerosis: The role of depression and fatigue.
    Mult Scler. 2025 Jun 11:13524585251338757. doi: 10.1177/13524585251338757.
    PubMed         Abstract available


    N Engl J Med

  38. ZHANG L, Gao Z, Pan H, Li R, et al
    BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy.
    N Engl J Med. 2025;392:2282-2284.
    PubMed        


    Neurol Clin Pract

  39. SALTER A, Lancia S, Sharma M, Cutter GR, et al
    Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis.
    Neurol Clin Pract. 2025;15:e200493.
    PubMed         Abstract available

  40. BALSHI A, Leuenberger G, Dempsey J, Manning N, et al
    Erratum: Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies: A Real-World Pharmacovigilance Study.
    Neurol Clin Pract. 2025;15:e200505.
    PubMed         Abstract available


    Neurology

  41. PETERSSON M, Jons D, Feresiadou A, Ilinca A, et al
    Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the Swedish Nationwide GEMG Study.
    Neurology. 2025;105:e213771.
    PubMed         Abstract available

  42. ZHOU J, Nilius S, Pilipczuk O, Scowcroft A, et al
    Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States: A Cohort Study Using Health Care Claims Databases.
    Neurology. 2025;105:e213736.
    PubMed         Abstract available


    PLoS One

  43. JEYABALAN A, Jhaveri KD, Bunke M, Briggs JA, et al
    Clinical study outcomes in IgA nephropathy: A systematic literature review and narrative synthesis.
    PLoS One. 2025;20:e0323530.
    PubMed         Abstract available

  44. JIANG W, Peng X, Dong L, Wu L, et al
    Predictors of neuropsychiatric manifestations in pediatric patients with lupus.
    PLoS One. 2025;20:e0325915.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A


  45. Editorial Expression of Concern for Poon et al., Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2025;122:e2512750122.
    PubMed        


    Thyroid

  46. VILLAGELIN D, Cooper DS, Burch HB
    Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists.
    Thyroid. 2025 May 28. doi: 10.1089/thy.2024.0759.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.